Other Clinical Trial - DAPHNE (Duodopa in Advanced Parkinson's: Health

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Advanced Idiopathic Parkinson's Disease
Parkinson Disease

See also
Status	Clinical Trial	Phase
Completed	`NCT01711866` - A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease	Phase 4
Completed	`NCT01744496` - Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain	Phase 4
Terminated	`NCT01519882` - Sleep Efficiency Assessed by Polysomnography (PSG Sleep Lab Testing) in Advanced Parkinson's Disease	Phase 4

See also

Status

Clinical Trial

Phase

Completed

NCT01711866 - A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease

Phase 4

Completed

NCT01744496 - Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain

Phase 4

Terminated

NCT01519882 - Sleep Efficiency Assessed by Polysomnography (PSG Sleep Lab Testing) in Advanced Parkinson's Disease

Phase 4

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00141518
Study type	Interventional
Source	Abbott
Contact
Status	Completed
Phase	Phase 4
Start date	January 2006
Completion date	April 2011

DAPHNE (Duodopa in Advanced Parkinson's: Health Outcomes & Net Economic Impact)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms